Quretech Bio Ab
QureTech Bio’s vision is to develop first line drugs to combat antibiotic resistance and infectious diseases. The global market for antibiotics is estimated at USD 38 billion with USA, Europe and Japan representing 50%. The cost of antibiotic resistance to medical communities in the EU alone is conservatively estimated to be €1.5 billion and the availability of new targeted antibiotics of this type would generate significant cost savings for healthcare systems.
7-day free trial · no credit card
Verified contacts
3
available on Kipplo
LinkedIn employees
8
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
0
tools in use
Monthly traffic
1
organic / mo
Sign up free to see all 3 verified contacts at Quretech Bio Ab
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
3 contacts with verified email or phone · masked until revealed.
- MB
Mari Bonde
Senior Scientist · Science
EmailPhone - AR
Annica Rönnbäck
Chief Operating Officer · General Business & Management
EmailPhone
Showing 2 of 3 verified contacts
Top roles at Quretech Bio Ab
2 distinct titles indexed · top 2 shown.
- 1chief operating officer
- 1senior scientist
Sign up to unlock all 3 contacts at Quretech Bio Ab
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 3 verified contacts at Quretech Bio Ab
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.